Physician profile
Richard Fei
NPI 1265428585
$3,142.97
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $683 · 2021: $590 · 2022: $25.38 · 2023: $32.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $708.42 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $535.27 | 2019-2021 | |
| Mylan Specialty L.P. | $289.00 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $258.12 | 2019-2021 | |
| Getinge USA Sales, LLC | $191.87 | 2019-2021 | |
| Grifols USA, LLC | $142.58 | 2019-2021 | |
| Genentech USA, INC. | $142.19 | 2019-2020 | |
| Genzyme Corporation | $139.06 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $126.70 | 2019-2020 | |
| Gilead Sciences, INC. | $104.62 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $94.42 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.54 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $59.08 | 2019-2022 | |
| Insmed, INC. | $43.49 | 2019-2021 | |
| United Therapeutics Corporation | $39.01 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.26 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $36.14 | 2021 | |
| Merck Sharp & Dohme LLC | $25.28 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $22.70 | 2020 | |
| Circassia INC. | $19.16 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.33 | 2021 | |
| Cook Medical LLC | $17.12 | 2019 | |
| La Jolla Pharmaceutical Company | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Fei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.